Innovation Pharmaceuticals Inc.
IPIX
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 86.07% | -11.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 37.56% | -9.05% | |||
| Operating Income | -37.56% | 9.05% | |||
| Income Before Tax | -29.22% | 2.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -29.22% | 2.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -29.22% | 2.44% | |||
| EBIT | -37.56% | 9.05% | |||
| EBITDA | -44.49% | 10.58% | |||
| EPS Basic | -30.77% | 7.14% | |||
| Normalized Basic EPS | -37.50% | 11.11% | |||
| EPS Diluted | -30.77% | 7.14% | |||
| Normalized Diluted EPS | -37.50% | 11.11% | |||
| Average Basic Shares Outstanding | 0.01% | 4.30% | |||
| Average Diluted Shares Outstanding | 0.01% | 4.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||